U.S. experience of immunomodulators in the treatment of psoriasis.
Weller
R
R
D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome; D006113:United Kingdom
D007155:Immunologic Factors; D007166:Immunosuppressive Agents